{
    "clinical_study": {
        "@rank": "87193", 
        "arm_group": [
            {
                "arm_group_label": "Botulinum toxin type A", 
                "arm_group_type": "Active Comparator", 
                "description": "The group that will be subjected to the injection of botulinum toxin (subcutaneous injection of botulinum toxin type A).Subcutaneous botulinum toxin A injection will be performed in this group, (2.5 units per point application), at one point in a nasal and temporal extent of the orbicularis muscle."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "The group that will not be subjected to any intervention."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to associate the use of botulinum toxin type A for patients\n      with keratoconus to demonstrate that tension eyelid has an important role in disease\n      progression."
        }, 
        "brief_title": "Botulinum Toxin A for the Treatment of Keratoconus", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Keratoconus", 
        "condition_browse": {
            "mesh_term": "Keratoconus"
        }, 
        "detailed_description": {
            "textblock": "Subcutaneous injection of type A botulinum toxin will be performed at one point in a nasal\n      and temporal extent of the orbicularis muscle of a group of patients with keratoconus\n      (Botulinum toxin A group).The idea is to evaluate the change in palpebral fissure in\n      patients from group botulinum toxin A over a period of one year.The measurements of the\n      palpebral fissure will be performed by the Image J (version  1.34s) program, developed by\n      the National Institutes of Health (USA).The unit of measure is the millimetre.The patients\n      of the botulinum toxin A group will be compared with a control group, without any\n      intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with documented keratoconus\n\n          -  best-corrected visual acuity measurable at refraction test\n\n          -  age between 10-40 years\n\n          -  good health\n\n          -  understand the procedure and its limitations\n\n        Exclusion Criteria:\n\n          -  only one functional eye\n\n          -  previous ocular surgery\n\n          -  concurrent corneal infection and other ocular diseases that modified the visual\n             acuity\n\n          -  known allergy to botulinum toxin\n\n          -  pregnancy\n\n          -  poor collaboration for performing the examinations and the procedure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01691651", 
            "org_study_id": "RECUNIFESP-87051"
        }, 
        "intervention": [
            {
                "arm_group_label": "Botulinum toxin type A", 
                "description": "Subcutaneous injection of botulinum toxin type A (2.5 units per application point) at one point in a nasal and temporal extent of the orbicularis muscle will be performed in the Botulinum toxin type A group.", 
                "intervention_name": "Subcutaneous injection of botulinum toxin type A", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Botulinum toxin type A", 
                "description": "2.5 units per point of application at one point in a nasal and temporal extent of the orbicularis muscle.", 
                "intervention_name": "Botulinum Toxin Type A", 
                "intervention_type": "Drug", 
                "other_name": "Botox (Allergan)"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Keratoconus", 
            "Tetanus toxin"
        ], 
        "lastchanged_date": "April 8, 2013", 
        "link": {
            "description": "Pubmed comprises citations for biomedical literature from MEDLINE, life science journals, and online books.", 
            "url": "http://pubmed.gov"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "zip": "04023-062"
                }, 
                "name": "Federal University of S\u00e3o Paulo, Department of Ophthalmology"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Botulinum Toxin A for the Treatment of Keratoconus", 
        "other_outcome": {
            "description": "We will evaluate the aberrometer (unit of measure=um[micra])by 1 year.These time points will be included:baseline, 3, 6, and 12 months.", 
            "measure": "Aberrometer", 
            "safety_issue": "No", 
            "time_frame": "One year."
        }, 
        "overall_official": [
            {
                "affiliation": "Federal University of S\u00e3o Paulo", 
                "last_name": "Adimara C Renesto, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Federal University of S\u00e3o Paulo", 
                "last_name": "Teissy H Osaki, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Federal University of S\u00e3o Paulo", 
                "last_name": "Midori H Osaki, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Federal University of S\u00e3o Paulo", 
                "last_name": "Mauro Q Campos, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will evaluate the change in palpebral fissure (unit of measure=millimetre)by 1 year.These time points will be included:baseline, 3, 6, and 12 months.", 
            "measure": "Measurement of the palpebral fissure", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "reference": [
            {
                "PMID": "9493273", 
                "citation": "Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319. Review."
            }, 
            {
                "PMID": "11778802", 
                "citation": "Edwards M, McGhee CN, Dean S. The genetics of keratoconus. Clin Experiment Ophthalmol. 2001 Dec;29(6):345-51. Review."
            }, 
            {
                "PMID": "14640429", 
                "citation": "Miranda D, Sartori M, Francesconi C, Allemann N, Ferrara P, Campos M. Ferrara intrastromal corneal ring segments for severe keratoconus. J Refract Surg. 2003 Nov-Dec;19(6):645-53."
            }, 
            {
                "PMID": "19772256", 
                "citation": "Kymionis GD, Kontadakis GA, Kounis GA, Portaliou DM, Karavitaki AE, Magarakis M, Yoo S, Pallikaris IG. Simultaneous topography-guided PRK followed by corneal collagen cross-linking for keratoconus. J Refract Surg. 2009 Sep;25(9):S807-11. doi: 10.3928/1081597X-20090813-09. Epub 2009 Sep 11."
            }, 
            {
                "PMID": "12719068", 
                "citation": "Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003 May;135(5):620-7."
            }, 
            {
                "PMID": "22265143", 
                "citation": "Renesto Ada C, Melo LA Jr, Sartori Mde F, Campos M. Sequential topical riboflavin with or without ultraviolet a radiation with delayed intracorneal ring segment insertion for keratoconus. Am J Ophthalmol. 2012 May;153(5):982-993.e3. doi: 10.1016/j.ajo.2011.10.014. Epub 2012 Jan 20."
            }, 
            {
                "PMID": "10906086", 
                "citation": "Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol. 2000 Aug;84(8):834-6."
            }, 
            {
                "PMID": "11004300", 
                "citation": "Kim T, Khosla-Gupta B, Debacker C. Blepharoptosis-induced superior keratoconus. Am J Ophthalmol. 2000 Aug;130(2):232-4."
            }, 
            {
                "PMID": "6830745", 
                "citation": "Parunovi\u0107 A. Floppy eyelid syndrome. Br J Ophthalmol. 1983 Apr;67(4):264-6."
            }, 
            {
                "PMID": "6018907", 
                "citation": "Brown IA. Ankyloblepharon associated with keratoconus. Br J Ophthalmol. 1967 Feb;51(2):138-9."
            }, 
            {
                "PMID": "16303509", 
                "citation": "Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003 Sep;26(3):139-46."
            }, 
            {
                "PMID": "3977705", 
                "citation": "Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985 Mar;103(3):347-50."
            }, 
            {
                "PMID": "16491229", 
                "citation": "Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review]. Arq Bras Oftalmol. 2006 Jan-Feb;69(1):23-6. Epub 2006 Feb 10. Review. Portuguese."
            }, 
            {
                "PMID": "21225137", 
                "citation": "Nicoletti AG, Aoki L, Nahas TR, Matayoshi S. [Essential blepharospasm: literature review]. Arq Bras Oftalmol. 2010 Sep-Oct;73(5):469-73. Review. Portuguese."
            }, 
            {
                "PMID": "20590421", 
                "citation": "Coscarelli JM. Essential blepharospasm. Semin Ophthalmol. 2010 May;25(3):104-8. Review."
            }, 
            {
                "PMID": "9584238", 
                "citation": "Krumeich JH, Daniel J, Kn\u00fclle A. Live-epikeratophakia for keratoconus. J Cataract Refract Surg. 1998 Apr;24(4):456-63."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01691651"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of S\u00e3o Paulo", 
            "investigator_full_name": "Adimara da Candelaria Renesto", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "We will evaluate corneal topography [flattest keratometry, steepest keratometry and average keratometry(unit of measure=diopters)]by 1 year.These time points will be included:baseline, 3, 6, and 12 months.", 
            "measure": "Corneal topography", 
            "safety_issue": "No", 
            "time_frame": "One year."
        }, 
        "source": "Federal University of S\u00e3o Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Federal University of S\u00e3o Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}